View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Johanna Jourdain
  • Johanna Jourdain
Johanna Jourdain
  • Johanna Jourdain
 PRESS RELEASE

Ipsen announces issuance of €500 million inaugural Rated Public Bond

Ipsen announces issuance of €500 million inaugural Rated Public Bond Transaction follows Investment Grade ratings assignment from both S&P and Moody’s PARIS, FRANCE, 19 March 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today announced the successful completion of its inaugural Rated Public Bond of €500 million with a coupon of 3.875%, maturing in March 2032. Following the disclosure of the Investment Grade ratings with BBB- from S&P and Baa3 from Moody’s, both with a stable outlook, this transaction was very well received and largely oversu...

 PRESS RELEASE

Ipsen annonce le succès de son émission obligataire inaugurale notée d...

Ipsen annonce le succès de son émission obligataire inaugurale notée d'un montant de 500 millions d'euros Cette transaction fait suite à l’attribution, par S&P et Moody’s, de notations de crédit ‘Investment Grade’ PARIS, FRANCE, 19 mars 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), groupe biopharmaceutique mondial de spécialité, a annoncé aujourd'hui, le succès de son émission obligataire inaugurale notée de 500 millions d'euros, assortie d'un coupon de 3.875%, et arrivant à échéance en mars 2032. Cette transaction, lancée peu après l’attribution par S&P et Moody’s de notations de crédit ‘...

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
 PRESS RELEASE

Ipsen appoints Olivia Brown as Executive Vice-President, Global Head o...

Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins PARIS, FRANCE, March 12th, 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven company, announced today the appointment of Olivia Brown as, EVP, Global Head of Neurotoxins, effective April 1st, 2025.  She will serve on Ipsen’s Executive Leadership Team (ELT) and report directly to Chief Executive Officer David Loew. In this newly created role, she will lead Ipsen’s global neurotoxins franchise, overseeing strategy and execution across both therapeutic and aesthetic indications. Over the...

 PRESS RELEASE

Ipsen nomme Olivia Brown au poste de Vice-Présidente Exécutive, Direct...

Ipsen nomme Olivia Brown au poste de Vice-Présidente Exécutive, Directrice Mondiale des Neurotoxines PARIS, FRANCE, 12 mars 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), groupe biopharmaceutique mondial de spécialité, a annoncé aujourd'hui la nomination d'Olivia Brown au poste de Vice-Présidente Exécutive, Directrice Mondiale des Neurotoxines, à compter du 1er avril 2025. Elle fera partie de l'équipe de direction d'Ipsen et sera directement rattachée au directeur général David Loew. Dans le cadre de ce poste nouvellement créé, elle dirigera la franchise mondiale des neurotoxines d'Ipsen, superv...

Jerôme Bodin ... (+2)
  • Jerôme Bodin
  • Stephane Houri

ODDO : Feedback from 9th ODDO BHF TMT Forum

Our two-day 9th virtual TMT Forum was attended by 32 listed companies and 292 investors. The trends in media seem to point to a correct start to the year. Telecom players are optimistic on the regulatory front (intra-market consolidation). Software & IT services and semis continue to see mixed trends, apart from in AI and some hopes that a few companies will benefit from the rise of defence spending. In terms of companies, the main positive messages came from Auto1, CMCOM, Indra, Infineon, Telec...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch